Molly Henderson - 14 Jul 2023 Form 4/A - Amendment Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
CFO and CBO
Signature
/s/ Larry Miller, Attorney-in-Fact for Molly Henderson
Issuer symbol
PHAT
Transactions as of
14 Jul 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
21 Jul 2023, 20:30:08 UTC
Date Of Original Report
17 Jul 2023
Previous filing
05 Jun 2023
Next filing
03 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Award $0 +25,000 +36% $0.000000 95,180 14 Jul 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted on July 14, 2023. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of July 14, 2023, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
F2 This amendment is being filed to correct the transaction price included in the Form 4 filed on behalf of the Reporting Person on July 17, 2023.
F3 Includes 1,674 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in July 2023.